Publications

Chinese economic growth slows down amid several downside risks

Covid-19 vaccine production and aging populations drive growth for pharmaceuticals industry

Robust growth expected in 2022

A vast market with growing sales opportunities

Robust output growth expected in 2022

Large backlog of medical treatments to sustain growth in the coming years

Healthy profit margins despite public pressure to lower sales prices

Growing share of generics could affect local producers

Increase in production of primary products planned to lower reliance on China

High days sales outstanding in the wholesalers segment

A major drug production hub with good growth prospects

Business margins expected to increase again in 2022

Stable profit margins despite inflationary pressures

Good growth prospects, but also constraints due to lower public healthcare spend

Sharp output growth in 2021 due to vaccine production

Turkish GDP growth slows down amid soaring inflation and currency volatility

While the global economic recovery from the pandemic is bumpy, we identify five bright spots for export opportunities

Economic growth in the oil-rich Gulf region is outpacing that of its energy-importing neighbours. Petrodollars give an extra boost to the economic rebound in MENA.

Many low-income countries face a triple crisis: the Covid-19 pandemic, rising debt levels and climate change. To tackle these challenges at once one of the solutions could be a debt-for-climate swap.

Robust growth outlook for India's economy in 2022, provided vaccination rollout is accelerated